HopeStage
Back to all studies
CompletedNCT01985581

Guanfacine Added to Stimulant Medication for Executive Skills in Children With ADHD

About this titleRead the official source — NCT01985581
Medication studyAges 6–12Canada
The study in practice

Understand this study

Who was this study for?

This study was for people with ADHD. Listed age limits: 6 years to 12 years. Other eligibility criteria applied.

Listed locations
OttawaSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateOctober 2013
Recruitment status
Completed
Enrollment listed in the registry
50
Sponsor
JPM van Stralen Medicine Professional
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Canada
Age range
From 6 Years to 12 Years
Official registry ID
NCT01985581
Official title
Show the full official title

A Single-Center, Randomized, Double Blind, Placebo-Controlled, Crossover Evaluation of the Effect of GXR as Adjunctive Treatment With Stimulant on Executive Function and Quality of Life at Home and School in Children With ADHD

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Ottawa

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is JPM van Stralen Medicine Professional, a pharmaceutical company.

Did this study involve medication?

Yes. The study involved medication, including Guanfacine extended release and Placebo.

Who was this study for?

This study was for people with ADHD. Listed age limits: 6 years to 12 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies